Back to the clinic as Fox supports trial of NeuroHealing's drooling drug in Parkinson's
This article was originally published in Scrip
Executive Summary
The private US firm NeuroHealing Pharmaceuticals has received an undisclosed grant from the Michael J Fox Foundation for Parkinson's Disease (MJFF) to progress a novel formulation of the anti-cholinergic tropicamide for sialorrhoea (uncontrolled drooling) in patients with Parkinson's.